TMED3 and osteosarcoma: Subsequent the loss/gain of function experiments showed that knockdown of RPS15A alleviated the promotion effects of TMED3 overexpression in osteosarcoma cells, especially in proliferation (Fig. 5B), colony formation (Fig. 5C), apoptosis (Fig. 5D) and migration (Fig. 5E, F).